Drug-set enrichment analysis: A novel tool to investigate drug mode of action

Bioinformatics

Volumn 32, Issue 2, 2016, Pages 235-241

  Napolitano, Francesco ^a   Sirci, Francesco ^a   Carrella, Diego ^a   Di Bernardo, Diego ^a,b  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CFTR PROTEIN, HUMAN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MOLECULAR LIBRARY; TRANSCRIPTOME;

CYSTIC FIBROSIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOLECULAR LIBRARY; MUTATION; PHARMACOLOGY; PHENOTYPE;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE EXPRESSION REGULATION; HUMANS; MUTATION; PHENOTYPE; SMALL MOLECULE LIBRARIES; TRANSCRIPTOME;

EID: 84959879519     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv536     Document Type: Article

References (22)

1. Bajorath, J. (2002) Integration of virtual and high-throughput screening. Nat. Rev. Drug Dis., 1, 882-894.
2. Bickle, M. (2010) The beautiful cell: high-content screening in drug discovery. Anal. Bioanal. Chem., 398, 219-226.
3. Caohuy, H. et al. (2009) Rescue of DeltaF508-CFTR by the SGK1/Nedd4-2 signaling pathway. J. Biol. Chem., 284, 25241-25253.
4. Carlile, G. W. et al. (2007) Correctors of protein trafficking defects identified by a novel high-throughput screening assay. Chembiochem Eur. J. Chem. Biol., 8, 1012-1020.
5. Carrella, D. et al. (2014) Mantra 2. 0: An online collaborative resource for drug mode of action and repurposing by network analysis. Bioinformatics, 30, 1787-1788.
6. Dai, M. et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res., 33, e175-e175.
7. Dokmanovic, M. et al. (2007) Histone deacetylase inhibitors: overview and perspectives. Mol. Cancer Res., 5, 981-989.
8. Durinck, S. et al. (2009)Mapping identifiers for the integration of genomic datasets with the r/bioconductor package biomaRt. Nat. Protocols, 4, 1184-1191.
9. Egan, M. E. et al. (2002) Calcium-pump inhibitors induce functional surface expression of F508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med., 8, 485-492.
10. Gautier, L. et al. (2004) affy-analysis of affymetrix GeneChip data at the probe level. Bioinformatics (Oxford, England), 20, 307-315.
11. Hanrahan, J. W. et al. (2013) Novel pharmacological strategies to treat cystic fibrosis. Trends Pharmacol. Sci., 34, 119-125.
12. Hutt, D. M. et al. (2010) Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat. Chem. Biol., 6, 25-33.
13. Iorio, F. et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl. Acad. Sci., 107, 14621-14626.
14. Lamb, J. et al. (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929-1935.
15. Maitra, R. et al. (2001) Increased functional cell surface expression of CFTR and DeltaF508-CFTR by the anthracycline doxorubicin. Am. J. Physiol. Cell Physiol., 280, C1031-C1037.
16. O'Sullivan, B. P. And Freedman, S. D. (2009) Cystic fibrosis. Lancet, 373, 1891-1904.
17. Robert, R. et al. (2010) Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine. Mol. Pharmacol., 77, 922-930.
18. Ruepp, A. et al. (2010) CORUM: The comprehensive resource of mammalian protein complexes-2009. Nucleic Acids Res., 38, D497-D501.
19. Sackrowitz, H. And Samuel-Cahn, E. (1999) P values as random variables expected P values. Am. Stat., 53, 326-331.
20. Sams-Dodd, F. (2005) Target-based drug discovery: is something wrong? Drug Dis. Today, 10, 139-147.
21. Srivastava, M. et al. (2004) Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. Proc. Natl. Acad. Sci. USA, 101, 7693-7698.
22. Subramanian, A. et al. (2005) Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA, 102, 15545-15550.